Introduction {#Sec1}
============

The koji mold *Aspergillus oryzae* is an important filamentous fungus used in the traditional Japanese fermentation industry to produce *sake* (rice wine), *shoyu* (soy sauce), and *miso* (soybean paste) (Machida et al. [@CR20]). Filamentous fungi are generally able to secrete large amounts of various hydrolytic enzymes. *Aspergillus oryzae* has a high potential for secretion of industrially important enzymes such as amylases and proteases (Kobayashi et al. [@CR14]; Machida et al. [@CR20]). In addition, its long history of extensive use in the food industry has placed *A. oryzae* on the list of Generally Recognized as Safe (GRAS) organisms compiled by the Food and Drug Administration (FDA) in the USA (Abe et al. [@CR1]). The safety of this organism is also supported by the World Health Organization (WHO) (FAO/WHO [@CR9]). Although *A. oryzae* is genetically very close to *Aspergillus flavus*, which produces many secondary metabolites, including the most potent natural carcinogen aflatoxin and the tremorgenic mycotoxin aflatrem, there is no record of *A. oryzae* producing any toxic metabolites because its secondary metabolite genes are silenced (Machida et al. [@CR19]). For instance, the *A. oryzae* homologs of the aflatoxin biosynthesis gene cluster are not expressed even under conditions that are favorable for aflatoxin production in *A. flavus* and *Aspergillus parasiticus* (Kusumoto et al. [@CR18]; Watson et al. [@CR42]; Takahashi et al. [@CR36]; Zhang et al. [@CR48]). Therefore, *A. oryzae* may be a suitable host for production of not only heterologous proteins but also secondary metabolites with important medical activities (Kobayashi et al. [@CR14]; Machida et al. [@CR20]; Sakai et al. [@CR35]).

Ustiloxin B is a toxic cyclic peptide that was originally identified in *Ustilaginoidea virens*, a pathogenic fungus affecting rice (Koiso et al. [@CR15], [@CR16], [@CR17]). Recently, the ustiloxin B biosynthetic gene cluster was identified in *A. flavus* using a novel method to predict gene clusters from transcriptome data, and subsequently validated by LC-MS analysis of ustiloxin B production by gene deletion mutants (Umemura et al. [@CR40], [@CR41]). Although ustiloxin B production by *A. oryzae* is undetectable under normal growth conditions, the corresponding gene cluster is present in the *A. oryzae* genome (Machida et al. [@CR19]; Umemura et al. [@CR40]); it contains 15 genes, including *ustR*, which encodes a fungal-type Zn(II)~2~Cys~6~ (C6) transcription factor (Umemura et al. [@CR40]). Interestingly, the upstream region of *ustR*, which might be involved in the transcriptional regulation of *ustR*, is deleted in *A. oryzae* (Umemura et al. [@CR40]).

Fungal secondary metabolites are biosynthesized by proteins encoded by clusters of coordinately regulated genes, and most of these clusters encode enzymes, such as polyketide synthase (PKS) and non-ribosomal peptide synthase (NRPS), which catalyze condensation reactions of monomeric units to form oligomeric intermediates. Ustiloxin B synthesis does not involve PKS or NRPS: this is the first case of a ribosomally synthesized peptide in a filamentous fungus (Umemura et al. [@CR41]). Ustiloxin B consists of tetrapeptides, Tyr-Ala-Ile-Gly (YAIG). It is circularized at the side chains of Tyr and Ile, and modified with a methyl group, a hydroxyl group, and the non-protein-coding amino acid norvaline; all three modifications are at the tyrosine (Umemura et al. [@CR41]). Since the protein encoded by *ustA* contains 16 repeats of YAIG, UstA is thought to be the precursor of ustiloxin B (Umemura et al. [@CR41]). The *U. virens* gene for the precursor (UstA) has five Tyr-Val-Ile-Gly (YVIG) and three YAIG motifs, corresponding to the sequences of ustiloxin A and ustiloxin B, respectively (Koiso et al. [@CR15], [@CR16]; Tsukui et al. [@CR39]). Thus, ustiloxins produced by *U. virens* (both are cyclic peptides) are probably synthesized via the ribosomal peptide synthesis (RiPS) pathway, as in the case of *A. flavus* ustiloxin B (Tsukui et al. [@CR39]).

In both *A. flavus* and *U. virens*, the UstA protein possesses an N-terminal signal peptide for import into the endoplasmic reticulum, followed by a novel repeating sequence containing basic amino acid doublets, KR, which resemble the target sites of the subtilisin-like endoprotease Kex2 from *Saccharomycescerevisiae* (Mizuno et al. [@CR28]; Fuller et al. [@CR11]). Kex2 of *S. cerevisiae* is a Ca^2+^-dependent transmembrane serine protease that cleaves secretory proproteins at the carboxyl side of KR and RR in a late Golgi compartment (Fuller et al. [@CR11]; Redding et al. [@CR34]). Therefore, the UstA proteins may be processed in the Golgi apparatus at the C-terminal side of KR by the KexB protease, which is an *A. oryzae* ortholog of *S. cerevisiae* Kex2 (Mizutani et al. [@CR29]). However, the relationship between the biosynthesis of RiPS compounds, such as ustiloxin B, and the KexB protease has not been characterized directly.

In the present study, we constructed several *ustR* expression (*ustR*^EX^) mutants of *A. oryzae* to determine whether they would be able to produce ustiloxin B, in contrast to the wild-type strain. Analyses of the transcription of ustiloxin B biosynthetic cluster genes in these strains revealed that *ustR* expression induced the expression of all other genes in the cluster and ustiloxin B production in the *ustR*^EX^ strains. Because *ustR* expression and ustiloxin B production were never detected in the wild-type strain, *A. oryzae* might silence *ustR*, resulting in the lack of ustiloxin B synthesis. The involvement of the KexB protease in the processing of the precursor protein, UstA, was validated by the analysis of ustiloxin B production in a *ustR*^EX^ strain with *kexB* deletion (*ustR*^EX^/∆*kexB*). We propose that the expression of the transcription factor *ustR* is critical for the production of ustiloxin B in *A. oryzae*, and that the KexB endopeptidase is involved in UstA processing.

Methods {#Sec2}
=======

Strains and growth media {#Sec3}
------------------------

*Aspergillus oryzae* strains used in this study are listed in Table [1](#Tab1){ref-type="table"}. RIB40 was used as the wild-type strain; ∆*ligD::sC*, ∆*kexB* and NSlD-∆P10 were used as parents to construct *ustR*-expressing (*ustR*^EX^) strains. These strains were grown in Czapek-Dox (CD) minimal medium or CDE medium, which is CD medium supplemented with 70 mM monosodium glutamate instead of sodium nitrate (NaNO~3~) as a nitrogen source for preparation of conidial suspension (Mizutani et al. [@CR30]). CDE medium containing 2 % maltose as a carbon source (designated CDEm medium) or YPM medium (1 % yeast extract, 2 % polypeptone, 2 % maltose) was used for up-regulation of *glaA142* promoter-driven *ustR* in the *ustR*^EX^ strains. To analyze gene transcription and to measure ustiloxin B production, strains were cultured in V8-juice liquid medium referred to hereafter as V8 medium \[20 % (v/v) V8 juice (Campbell's, Camden, NJ, USA) with 0.3 % CaCO~3~\] at 30 °C on a rotary shaker at 160 rpm.Table 1Strains used in this studyStrainParental strainGenotypeSource or referenceRIB40Wild typeMachida et al. ([@CR19])∆*ligD::sC*NS4^a^*sC* ^-^, *niaD* ^-^, ∆*ligD::sC*Mizutani et al. ([@CR30])*ustR* ^EX^-G101∆*ligD::sCsC*, *niaD* ^-^, ∆*ligD::sC*, P*glaA142*-*ustR::niaD*This study*ustR* ^EX^-G301∆*ligD::sCsC*, *niaD* ^-^, ∆*ligD::sC*, P*glaA142*-*ustR::niaD*This study∆*kexB*niaD300^b^*niaD* ^-^, ∆*kexB::ptrA*Kindly provided by Dr. Y. Yamagata*ustR* ^EX^/∆*kexB*∆*kexBniaD* ^-^, ∆*kexB::ptrA*, P*glaA142*-*ustR::niaD*This studyNSlD-∆P10NSPlD-tApEnBdIVdVaApApAapAd1*sC*, *niaD* ^-^, *adeA* ^-^, ∆*argB::adeA* ^-^, ∆*ligD::argB*, ∆*pyrG::adeA*, ∆*tppA*, ∆*pepE*, ∆*nptB*, ∆*dppIV*, ∆*dppV*, ∆*alpA*, ∆*pepA*, ∆*AopepAa*, ∆*AopepAd*, ∆*cpI::pyrG*Yoon et al. ([@CR45])*ustR* ^EX^/∆P10NSlD-∆P10*sC*, *niaD* ^-^, *adeA* ^-^, ∆*argB::adeA* ^-^, ∆*ligD::argB*, ∆*pyrG::adeA*, ∆*tppA*, ∆*pepE*, ∆*nptB*, ∆*dppIV*, ∆*dppV*, ∆*alpA*, ∆*pepA*, ∆*AopepAa*, ∆*AopepAd*, ∆*cpI::pyrG*, P*glaA142*-*ustR::niaD*This study^a^Yamada et al. ([@CR44])^b^Minetoki et al. ([@CR25])

Construction of *ustR* expression mutants in *A. oryzae* {#Sec4}
--------------------------------------------------------

The plasmid for *ustR* expression was constructed as follows. The *A. oryzae ustR* gene was amplified using KOD-plus DNA polymerase (Toyobo, Osaka, Japan) and the primers ustR-MCS-F and ustR-MCS-R (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Each primer was designed to introduce a *Not*I site. *Aspergillusoryzae* RIB40 genomic DNA was used as the template. The amplified fragment was digested with *Not*I and inserted into the *Not*I site of pNGA142 (Minetoki et al. [@CR26], [@CR27]), which contained the *glaA142* promoter, *agdA* terminator, and *niaD* gene as a selectable marker in *A. oryzae*. The resulting plasmid (pNGAustR) was used to transform the ∆*ligD::sC*, ∆*kexB*, and NSlD-∆P10 strains and was integrated into their genomes as described previously (Fujioka et al. [@CR10]). Two mutant lines of *ustR*^EX^, designated G101 and G301, were obtained by transformation of the parental strain ∆*ligD::sC* strain; both G101 and G301 were used in the following experiments.

Analysis of the transcription levels of the ustiloxin B gene cluster by quantitative RT-PCR {#Sec5}
-------------------------------------------------------------------------------------------

Real-time RT-PCR was performed as described previously (Yoshimi et al. [@CR46], [@CR47]). Primer sets for quantifying the expression of the ustiloxin B cluster genes are listed in Additional file [1](#MOESM1){ref-type="media"}: Table S1. The histone H2B gene was used as a normalization reference (internal control) for target gene expression ratios. A sample of unmanipulated cells of the control strain (∆*ligD::sC*) cultured in V8 medium was set as a calibrator in each experiment. Statistical analyses were performed using Welch's *t* test (*p* \< 0.01 was considered significant).

Production of ustiloxin B {#Sec6}
-------------------------

Three replicates of the control and each *ustR*^EX^ strain were cultivated in 100 mL of V8 medium in 200-mL Erlenmeyer flasks at 30 °C and 160 rpm. After 1, 3, 5, and 7 days, 10-mL culture aliquots were harvested and the equivalent volume of acetone was added. The mixtures were incubated for 1 h at room temperature, and the mycelia were removed by filtration through Miracloth. Each filtrate was stirred with an equal amount of ethyl acetate for 1 h at room temperature, centrifuged at 13,000×*g* for 10 min, and the water layer was collected. A 3-μL aliquot of each water extract was separated using an UPLC-MS system (Acquity UPLC I-Class, Xevo G2 QTof, Waters Corp., MA, Milford, USA) equipped with a reversed-phase column (2.1 × 150 mm; Acquity UPLC BEH C18; Waters Corp.) Peptides were eluted with a water--acetonitrile gradient containing 0.1 % formic acid (98:2 for 0.5 min, to 70:30 for 10 min) at a flow rate of 0.4 mL/min. The production of ustiloxin B (C~26~H~39~N~5~O~12~S) was quantified by calculating the peak area of extracted ion chromatograms (EICs) of m/z 646.239 ± 0.03 \[M + H\]^+^ at the retention time of 3.1 min. An authentic sample of ustiloxin B (Umemura et al. [@CR40]) was used for external calibration with the QuanLynx software (version 4.1, Waters Corp.).

Results {#Sec7}
=======

Expression of *ustR* in *A. oryzae* {#Sec8}
-----------------------------------

In the wild-type strain, no transcript of the *ustR* gene was detected at the time points examined (Fig. [1](#Fig1){ref-type="fig"}), whereas in the *ustR*^EX^ strains the *ustR* transcript was detectable in CDEm (data not shown) and V8 media (Fig. [1](#Fig1){ref-type="fig"}). There were no notable differences between the two independent *ustR*^EX^ mutant lines (G101 and G301; Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Expression of the *ustR* gene in wild-type (RIB40) and *ustR* ^EX^ (G101 and G301) *A. oryzae* strains. The strains were grown in V8 medium at 30 °C. Quantitative RT-PCR was used to determine the levels of transcription of the *ustR* gene and was performed on total RNA with *ustR*-specific primers (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Each value represents the ratio of *ustR* expression to that of the histone H2B gene in each strain. *Error bars* represent standard deviations (*n* = 3). *ND* not detectable

Next, we analyzed the expression of the other 14 genes in the ustiloxin B biosynthetic cluster to test whether it is affected by *ustR* expression. Whereas the transcripts of all these genes (except *ustH*) were undetectable in the wild-type strain, they were strongly induced in both *ustR*^EX^ strains grown in V8 medium for 5 days (Fig. [2](#Fig2){ref-type="fig"}). The transcripts of all genes were present from day 1 until at least 7 days after inoculation (Fig. [2](#Fig2){ref-type="fig"}; Additional file [1](#MOESM1){ref-type="media"}: Figures S1, S2, S3), in line with the expression of *ustR* (Fig. [1](#Fig1){ref-type="fig"}). The co-expression of *ustR* and other genes of this cluster was also detected in CDEm and YPM liquid media (data not shown). These results suggest that the C6-type transcription factor UstR regulates all genes in the ustiloxin B biosynthetic cluster.Fig. 2Expression of the genes of the cluster for ustiloxin B biosynthesis in *A. oryzae* wild-type (RIB40) and *ustR* ^EX^ (G101 and G301) strains. The strains were grown in V8 medium at 30 °C for 5 days. Quantitative RT-PCR was used to determine the levels of transcription and was performed on total RNA with gene-specific primers (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Each value represents the ratio of expression to that of the histone H2B gene in each strain. *Error bars* represent standard deviations (*n* = 3). *ND* not detectable

Production of ustiloxin B in the *ustR*^EX^ mutants {#Sec9}
---------------------------------------------------

To investigate whether *ustR* expression induces ustiloxin B production, we assessed the presence of ustiloxin B in both *ustR*^EX^ strains, G101 and G301. Although the genes in the ustiloxin B cluster were transcribed in CDEm or YPM media in the *ustR*^EX^ strains, the production of ustiloxin B was not detected (data not shown). However, ustiloxin B was detected in V8 medium culture, and its concentration increased continuously at least from 1 to 7 days (Fig. [3](#Fig3){ref-type="fig"}). These results indicate that ustiloxin B can be produced in *A. oryzae*, and that *ustR* expression and consequent induction of the genes of the ustiloxin B biosynthetic cluster are responsible for its production.Fig. 3Production of ustiloxin B by *A. oryzae* *ustR* ^EX^ (G101 and G301) strains. The strains were grown in V8 medium at 30 °C. Culture aliquots (10 mL) were harvested at the indicated time points and the amount of ustiloxin B in the culture medium was determined by LC-MS analysis. *Error bars* represent standard deviations (*n* = 3)

Involvement of the KexB protease in ustiloxin B biosynthesis in *A. oryzae* {#Sec10}
---------------------------------------------------------------------------

To investigate whether the precursor protein UstA was processed by KexB, we used the *ustR*^EX^ mutant lacking this protease (*ustR*^EX^/*∆kexB*). The transcription levels of the ustiloxin B biosynthetic genes and *ustR* were similar in the *ustR*^EX^/*∆kexB* and *ustR*^EX^ strains grown in V8 medium (Figs. [2](#Fig2){ref-type="fig"}, [4](#Fig4){ref-type="fig"}; Additional file [1](#MOESM1){ref-type="media"}: Figure S4). We then analyzed ustiloxin B production in both *ustR*^EX^ strains (*ustR*^EX^ and *ustR*^EX^/*∆kexB*) and the corresponding control strains (wild-type and *∆kexB*) (Table [1](#Tab1){ref-type="table"}). After 5 days of culture in V8 medium, ustiloxin B was not detectable in the control strains; a considerable amount of ustiloxin B (approximately 7 mg/L) was produced by the *ustR*^EX^ strain, but ustiloxin B was barely detectable in the *ustR*^EX^/∆*kexB* strain (approximately 0.35 mg/L; Fig. [5](#Fig5){ref-type="fig"}).Fig. 4Expression of the genes of the cluster for ustiloxin B biosynthesis in *A. oryzae* wild-type (RIB40), *ustR* ^EX^, ∆*kexB*, and *ustR* ^EX^/∆*kexB* strains. The strains were grown in V8 medium at 30 °C for 5 days. Quantitative RT-PCR was used to determine the levels of transcription of the *ustR* gene and the indicated representative genes; RT-PCR was performed on total RNA with gene-specific primers (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Each value represents the ratio of expression relative to that of the histone H2B gene in each strain. *Error bars* represent standard deviations (*n* = 3). *ND* not detectableFig. 5Production of ustiloxin B by *A. oryzae* wild-type (RIB40), *ustR* ^EX^, ∆*kexB*, *ustR* ^EX^/∆*kexB*, NSlD-∆P10, and *ustR* ^EX^/∆P10 strains. The strains were grown in V8 medium at 30 °C for 5 days. Culture aliquots (10 mL) were harvested and the amount of ustiloxin B in the culture medium was determined by LC-MS analysis. *Error bars* represent standard deviations (*n* = 3)

We also generated a *ustR*^EX^ mutant in the NSlD-∆P10 strain, in which the genes encoding 10 secreted proteases of *A. oryzae* are disrupted (Yoon et al. [@CR45]). The *ustR*^EX^/∆P10 strain produced the same level of ustiloxin B as the *ustR*^EX^ strain, whereas the parental strain, NSlD-∆P10, did not produce ustiloxin B (Fig. [5](#Fig5){ref-type="fig"}). These results suggest that KexB is critical for ustiloxin B production and is specifically required for proteolytic processing of the precursor protein UstA.

Discussion {#Sec11}
==========

In the present study, we analyzed the transcription of the ustiloxin B gene cluster and the production of ustiloxin B in three types of *ustR*^EX^ mutants of *A. oryzae* and their parental strains (wild-type *A. oryzae* RIB40, ∆*kexB*, and ∆P10) (Table [1](#Tab1){ref-type="table"}). In the wild-type strain, we detected neither the transcripts of any genes of the cluster nor ustiloxin B. In contrast, expression of the *ustR* gene (which encodes a fungal-type C6 transcription factor) from this cluster (Umemura et al. [@CR41]) up-regulated the transcription of all other genes of the cluster and induced ustiloxin B synthesis (Figs. [1](#Fig1){ref-type="fig"}, [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"}). Fungal-type Zn(II)~2~Cys~6~ (C6) transcription factors regulate genes involved in the production of secondary metabolites in filamentous fungi (Payne et al. [@CR33]; Chang et al. [@CR8]; Brown et al. [@CR7]; Marui et al. [@CR22]). One of the best-studied examples is AflR of *A. flavus*, *A. parasiticus*, and *A. nidulans*, which regulates the expression of genes required for the production of aflatoxin and sterigmatocystin (Payne et al. [@CR33]; Chang et al. [@CR8]; Brown et al. [@CR7]). In *A. oryzae*, fungal-type C6 transcription factors regulate genes necessary for the degradation of complex polysaccharides such as starch and xylan. For example, AmyR regulates the expression of the clustered amylolytic genes *agdA*, which encodes α-glucosidase, and *amyA*, which encodes α-amylase (Gomi et al. [@CR12]). In *A. oryzae*, XlnR regulates the expression of more than 30 xylanolytic and cellulolytic genes involved in the degradation of β-1,4-xylan, arabinoxylan, cellulose, and xyloglucan (Noguchi et al. [@CR31]), and ManR regulates the expression of the endo-β-mannanase gene (Ogawa et al. [@CR32]). In contrast, little is known about the role of fungal-type C6 transcription factors in the regulation of the expression of the genes involved in production of secondary metabolites synthesized through the RiPS pathway in *A. oryzae*.

The *A. oryzae* genome contains many gene clusters likely involved in biosynthesis of secondary metabolites, and these clusters are highly enriched in non-syntenic blocks (NSBs) (Machida et al. [@CR19], [@CR20]; Kobayashi et al. [@CR14]). The analyses of ESTs and DNA microarrays of *A. oryzae* grown under several conditions showed that the transcription levels of the NSB genes are considerably lower than those of the genes in syntenic blocks (Machida et al. [@CR19]; Akao et al. [@CR2]; Tamano et al. [@CR37]). The absence of toxin production in *A. oryzae* is thought to be attributable to silencing of the secondary metabolite biosynthetic genes (Barbesgaard et al. [@CR4]; Machida et al. [@CR20]; Tokuoka et al. [@CR38]). *Aspergillus oryzae* may possess a silencing mechanism similar to that observed in the regulation of aflatoxin biosynthesis in *Aspergillus sojae*, which is closely related to *A. oryzae* and is also known as koji mold. Silencing is thought to be caused by the lack of *aflR* expression and/or by non-functional AflR in *A. sojae* (Matsushima et al. [@CR23], [@CR24]). AflR regulates transcription of a gene cluster for aflatoxin biosynthesis in *Aspergillus* species (Woloshuk et al. [@CR43]). Although the *aflR* gene is present within the aflatoxin biosynthesis gene cluster, *aflR* is not expressed or AflR is non-functional in *A. oryzae* and *A. sojae* (Kusumoto et al. [@CR18]; Watson et al. [@CR42]; Takahashi et al. [@CR36]). The mechanism of *ustR* expression silencing may be similar to that of *aflR* expression silencing in *A. oryzae*.

The deletion of the upstream region of *ustR* might silence the ustiloxin B gene cluster in *A. oryzae*, resulting in the lack of ustiloxin B production even under conditions that are favorable for ustiloxin B production in *A. flavus*. However, some wild-type *A. oryzae* strains have no deletion in the *ustR* upstream region and are in this respect similar to *A. flavus* (our unpublished data). Therefore, this deletion is strain-specific in *A. oryzae* and might not affect ustiloxin B production. *Aspergillus oryzae* has orthologs of VelB, VeA, and LaeA (Marui et al. [@CR21]), which are global regulators of secondary metabolic genes in *Aspergillus* species (Bok and Keller [@CR6]; Bayram et al. [@CR5]; Amare and Keller [@CR3]). The absence of *aflR* expression was found in the ∆*laeAA. oryzae* strain (Ken Oda, personal communication), suggesting that *aflR* expression is regulated by LaeA in *A. oryzae*, as in other *Aspergillus* species. Thus, another possible explanation of ustiloxin B gene cluster silencing in *A. oryzae* is that global regulators of secondary metabolic genes such as LaeA might regulate *ustR* expression.

Although the expression of the *ustR* gene and the induction of the cluster genes were confirmed in the *ustR*^EX^ strain, the production of ustiloxin B was not detected in CDEm liquid medium, in which the *ustR*^EX^ strain was grown. Similar results were obtained in *A. flavus* (our unpublished data). Ustiloxin B production was also not detected in the nutritionally rich YPM liquid medium (our unpublished data). Ustiloxin B was produced by the *ustR*^EX^ strain only in V8 medium or cracked-maize medium (Fig. [3](#Fig3){ref-type="fig"} and data not shown). These data suggest that the amounts of amino acids were insufficient for ustiloxin B production in CDEm medium or that some essential factor(s), such as vitamin(s), derived from vegetables or maize is(are) needed for ustiloxin B production by *A. oryzae* even in the presence of sufficient amounts of amino acids in YPM medium.

Our data revealed that KexB endopeptidase is required for the processing of UstA, the ustiloxin B precursor, which contains a sequence with signal peptide characteristics and was predicted to be processed by the subtilisin-like endoprotease Kex2 (Umemura et al. [@CR41]). However, a low level of ustiloxin B production was still detectable in the *ustR*^EX^/*∆kexB* strain. This residual ustiloxin B production can be explained as follows: (1) in the absence of KexB, the expression of *ustA* was still up-regulated by the expression of *ustR*, resulting in sufficient amounts of UstA; (2) a small amount of UstA could be processed non-specifically by some protease(s) in the Golgi apparatus and produce low levels of ustiloxin B; (3) subsequent biosynthetic steps of ustiloxin B production could progress regardless of the presence or absence of KexB. A recent study on the biosynthesis of RiPS compounds in other fungal species predicted that the precursor protein of novel cyclic oligopeptides is likely to be processed by the subtilisin-like endoprotease in the ascomycetes *Epichloë* (Johnson et al. [@CR13]). Our study provides the first direct evidence that a subtilisin-like endoprotease is involved in the biosynthesis of a RiPS compound (ustiloxin B) in filamentous fungi.

Since the *A. oryzae* genome encodes a number of various proteases (Machida et al. [@CR19]; Kobayashi et al. [@CR14]), the identification of the protease potentially involved in UstA processing in the absence of KexB is quite difficult. However, ustiloxin B production was not altered in the *ustR*^EX^/∆P10 strain (Fig. [5](#Fig5){ref-type="fig"}), which expresses *ustR* and in which genes encoding 10 secreted proteases (TppA, PepE, NptB, DppIV, DppV, AlpA, PepA, AoPepAa, AoPepAd, and CpI) are disrupted (Table [1](#Tab1){ref-type="table"}) (Yoon et al. [@CR45]). Therefore, none of these 10 proteases is involved in UstA processing. Further studies are necessary for elucidation of the biosynthetic pathway of ustiloxin B in *A. oryzae*.
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10.1186/s13568-016-0181-4 PCR primers used in this study.**Figure S1.** Expression of the genes of the cluster for ustiloxin B biosynthesis in *A. oryzae* wild-type (RIB40) and *ustR* ^EX^ (G101 and G301) strains grown for 1 day. **Figure S2. **Expression of the genes of the cluster for ustiloxin B biosynthesis in *A. oryzae* wild-type (RIB40) and *ustR* ^EX^ (G101 and G301) strains grown for 3 day. **Figure S3.** Expression of the genes of the cluster for ustiloxin B biosynthesis in *A. oryzae* wild-type (RIB40) and *ustR* ^EX^ (G101 and G301) strains grown for 7 day. **Figure S4.** Expression of the genes of the cluster for ustiloxin B biosynthesis in the *A. oryzae* strains ∆*kexB*, *ustR* ^EX^/∆*kexB*, NSlD-∆P10 (∆*P10*), and *ustR* ^EX^/∆P10.
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